EUVIMEDEUVIMED entdecken
Crossref

CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages

Zhicheng Pan, Jialan Lv, Liding Zhao, Kaidi Xing, Runze Ye, Yuesheng Zhang, Siyuan Chen, Peng Yang, Hailong Yu, Yangkai Lin, Ruobing Li, Dongfei Wang und 9 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Zhicheng Pan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Angina, Stable, Disease Models, Animal, ELAV-Like Protein 1. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Plan of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Circular RNAs (circRNAs) are considered important regulators of biological processes, but their impact on atherosclerosis development, a key factor in coronary artery disease (CAD), has not been fully elucidated. We aimed to investigate their potential use in patients with CAD and the pathogenesis of atherosclerosis. Methods and results Patients with stable angina (SA) or acute coronary syndrome (ACS) and controls were selected for transcriptomic screening and quantification of circRNAs in blood cells. We stained carotid plaque samples for circRNAs and performed gain- and loss-of-function studies in vitro. Western blots, protein interaction analysis, and molecular approaches were used to perform the mechanistic study. ApoE−/− mouse models were employed in functional studies with adeno-associated virus-mediated genetic intervention. We demonstrated elevated circARCN1 expression in peripheral blood mononuclear cells from patients with SA or ACS, especially in those with ACS. Furthermore, higher circARCN1 levels were associated with a higher risk of developing SA and ACS. We also observed elevated expression of circARCN1 in carotid artery plaques. Further analysis indicated that circARCN1 was mainly expressed in monocytes and macrophages, which was also confirmed in atherosclerotic plaques. Our in vitro studies provided evidence that circARCN1 affected the interaction between HuR and ubiquitin-specific peptidase 31 (USP31) mRNA, resulting in attenuated USP31-mediated NF-κB activation. Interestingly, macrophage accumulation and inflammation in atherosclerotic plaques were markedly decreased when circARCN1 was knocked down with adeno-associated virus in macrophages of ApoE−/− mice, while circARCN1 overexpression in the model exacerbated atherosclerotic lesions.

Conclusions

Our findings provide solid evidence macrophagic-expressed circARCN1 plays a role in atherosclerosis development by regulating HuR-mediated USP31 mRNA stability and NF-κB activation, suggesting that circARCN1 may serve as a factor for atherosclerotic lesion formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeAngina, StableDisease Models, AnimalELAV-Like Protein 1MacrophagesPlaque, AtheroscleroticRNA, CircularRNA, MessengerSignal TransductionUbiquitin ThiolesteraseAgedAnimalsFemaleHumansMaleMiceMiddle AgedAtherosclerosisCarotid Artery DiseasesCase-Control StudiesCoronary Artery DiseaseGene Expression RegulationMice, Inbred C57BLMice, Knockout, ApoENF-kappa BRAW 264.7 CellsTHP-1 CellsUbiquitin-Specific Proteases

Stichwörter der Autor:innen

AtherosclerosisInflammationMacrophagescircARCN1circRNA

Substanzen

ELAV-Like Protein 1ELAVL1 protein, humanNF-kappa BRNA, CircularRNA, MessengerUbiquitin ThiolesteraseUbiquitin-Specific Proteases

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Province Key Laboratory of Pancreatic Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of USTC, The RNA Institute, School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China (UTSC),…
  • Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Pathology and Pathophysiology, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Ge Shan, Qingbo Xu, Xiaogang Guo

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Plan of Zhejiang Province

Zitieren

APA

Pan, Z., Lv, J., Zhao, L., Xing, K., Ye, R., Zhang, Y., Chen, S., Yang, P., Yu, H., Lin, Y., Li, R., Wang, D., Fang, J., Dong, Y., Sheng, J., Wang, X., Shan, G., Zhang, S., Cheng, H., …, & Guo, X. (2024). CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae148

Vancouver

Pan Z, Lv J, Zhao L, Xing K, Ye R, Zhang Y, et al. CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae148

BibTeX
@article{Pan2024,
  author = {Pan, Zhicheng and Lv, Jialan and Zhao, Liding and Xing, Kaidi and Ye, Runze and Zhang, Yuesheng and Chen, Siyuan and Yang, Peng and Yu, Hailong and Lin, Yangkai and Li, Ruobing and Wang, Dongfei and Fang, Juan and Dong, Yang and Sheng, Jianpeng and Wang, Xiaolin and Shan, Ge and Zhang, Shan and Cheng, Hongqiang and Xu, Qingbo and Guo, Xiaogang},
  title = {CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae148}
}
Kostenlos starten →